Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis (Q39816110)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis (English)

1 reference

Europe PubMed Central

14 September 2017

methicillin-resistant Staphylococcus aureus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

author name string

Dworkin R

1

1 reference

Europe PubMed Central

14 September 2017

Modin G

2

1 reference

Europe PubMed Central

14 September 2017

Kunz S

3

1 reference

Europe PubMed Central

14 September 2017

Rich R

4

1 reference

Europe PubMed Central

14 September 2017

Zak O

5

1 reference

Europe PubMed Central

14 September 2017

Sande M

6

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

1 June 1990

1 reference

Europe PubMed Central

14 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

14 September 2017

34

1 reference

Europe PubMed Central

14 September 2017

6

1 reference

Europe PubMed Central

14 September 2017

1014-1016

1 reference

Europe PubMed Central

14 September 2017

Model of experimental chronic osteomyelitis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

22 September 2017

Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

22 September 2017

Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

22 September 2017

In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

22 September 2017

Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

22 September 2017

Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

15 June 2018

Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

15 June 2018

Rifampin: Mechanisms of Action and Resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

15 June 2018

Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

15 June 2018

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

15 June 2018

Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171748

20 August 2018

Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2393259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute osteomyelitis in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/2393259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antibiotic therapy of skeletal infections in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/2393259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.34.6.1014

1 reference

Europe PubMed Central

14 September 2017

release_rp5vhkfiarft5paw6felv3rplq

0 references

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39816110&oldid=2090836976"